Evidence map›Paper›PMID 32821481›Full record

ArticleTranslational vision science & technology2020

Assessment of Choroidal Neovascularization Perfusion: A Pilot Study With Laser Speckle Flowgraphy.

Giacomo Calzetti, Paolo Mora, Stefania Favilla, Giorgia Ottonelli, Giulia Devincenzi, Arturo Carta, Salvatore Tedesco, Anna Mursch-Edlmayr, Gerhard Garhöfer, Stefano Gandolfi and 1 more

Abstract read
In one paragraph

Article in Translational vision science & technology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Imposed positive defocus changes choroidal blood flow in young human subjects.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Giacomo CalzettiOphthalmology Unit, University Hospital of Parma, Parma, Italy.
Paolo MoraOphthalmology Unit, University Hospital of Parma, Parma, Italy.
Stefania FavillaIndependent Researcher, Parma, Italy.
Giorgia OttonelliOphthalmology Unit, University Hospital of Parma, Parma, Italy.
Giulia DevincenziOphthalmology Unit, University Hospital of Parma, Parma, Italy.
Arturo CartaOphthalmology Unit, University Hospital of Parma, Parma, Italy.
Salvatore TedescoOphthalmology Unit, University Hospital of Parma, Parma, Italy.
Anna Mursch-EdlmayrDepartment of Ophthalmology, Kepler University Clinic, Johannes Kepler University, Linz, Austria.
Gerhard GarhöferDepartment of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
Stefano GandolfiOphthalmology Unit, University Hospital of Parma, Parma, Italy.
Leopold SchmettererDepartment of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The purpose of this study was to quantify perfusion in the area of choroidal neovascularization (CNV) using laser speckle flowgraphy (LSFG) before and after intravitreal anti-vascular endothelial growth factor (VEGF) injection. Methods: Retrospective case series. Fifteen eyes of 15 patients with treatment-naïve CNV due to age-related macular degeneration (AMD) and with available LSFG images were included. The main outcome was the mean blur rate (MBR) quantified as a measure of perfusion within the CNV area observed on indocyanine green angiography. Twelve patients had available longitudinal data until one month after the injection, used to evaluate changes in perfusion, central macular thickness (CMT), visual acuity, and ocular perfusion pressure. Reproducibility of LSFG measurements was investigated at each time point from two images taken within five minutes. Results: Intraclass correlation coefficients for LSFG measurements were higher than 0.8 indicating excellent reproducibility. There was a significant decrease in perfusion after one week (-26.4 ± 14.4%; Conclusions: This pilot study suggests a method to select a region in the CNV area to quantify perfusion using LSFG. MBR could represent a parameter possibly related to regrowth of the CNV after anti-VEGF treatment. Large-scale studies are needed to assess the usefulness of LSFG in defining re-treatment criteria for neovascular AMD. Translational Relevance: LSFG technology to quantify perfusion could provide useful biomarkers for therapeutic management of CNV.

Indexed as

Choroidal NeovascularizationWet Macular DegenerationAngiogenesis InhibitorsHumansLasersPerfusionPilot ProjectsReproducibility of ResultsRetrospective StudiesVascular Endothelial Growth Factor AVisual AcuityAngiogenesis InhibitorsVascular Endothelial Growth Factor Aage-related macular degenerationanti-VEGFchoroidimaginglaser speckle flowgraphy

Identifiers

PMID32821481
PMCPMC7401962

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.